Farzana Perwad Selected Research

burosumab

1/2021	Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension.
1/2021	Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia.
1/2020	Burosumab in X-linked hypophosphatemia and perspective for chronic kidney disease.
9/2019	Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.
1/2019	Fibroblast growth factor 23 and phosphate homeostasis.
1/2019	Burosumab Therapy for X-Linked Hypophosphatemia and Therapeutic Implications for CKD.
1/2019	Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.
1/2018	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Farzana Perwad Research Topics

Disease

9	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2021 - 11/2007
7	Chronic Renal Insufficiency 01/2022 - 01/2018
6	Hypophosphatemia 01/2021 - 11/2007
5	Rickets (Rachitis) 01/2021 - 08/2007
3	Pain (Aches) 01/2021 - 01/2018
3	Proteinuria 07/2020 - 11/2016
3	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 07/2020 - 12/2018
2	Fatigue 01/2021 - 01/2021
2	Bone Diseases (Bone Disease) 07/2020 - 04/2012
2	Inflammation (Inflammations) 10/2019 - 01/2018
2	Hypophosphatemic Rickets 01/2019 - 11/2007
1	Hyperparathyroidism 01/2022
1	Congenital Abnormalities (Deformity) 01/2021
1	Hyperphosphatemia 01/2021
1	Cystinuria 01/2020
1	Kidney Calculi (Kidney Stone) 01/2020
1	Neuroblastoma 10/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2019
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2019
1	Calcinosis 12/2018
1	Familial Hyperphosphatemic Tumoral Calcinosis 12/2018
1	Hyperostosis-hyperphosphatemia syndrome 12/2018
1	Kidney Diseases (Kidney Disease) 12/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Osteoarthritis 01/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2018
1	Nephrocalcinosis 01/2018
1	Oncogenic osteomalacia 11/2007
1	Hypocalcemia 08/2007

Drug/Important Bio-Agent (IBA)

11	Phosphates (Orthophosphate)IBA 01/2021 - 11/2007
9	Fibroblast Growth Factor-23IBA 01/2021 - 11/2007
8	burosumabIBA 01/2021 - 01/2018
6	MineralsIBA 01/2022 - 11/2016
6	hydroxide ionIBA 07/2020 - 11/2007
5	Phosphorus (Red Phosphorus)IBA 01/2022 - 12/2018
5	1,25-dihydroxyvitamin DIBA 01/2015 - 08/2007
4	Vitamin D FDA LinkGeneric 01/2021 - 08/2007
3	Monoclonal AntibodiesIBA 01/2021 - 01/2018
3	CalciumIBA 07/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
1	NucleotidesIBA 01/2022
1	Thioctic Acid (Lipoic Acid)IBA 01/2020
1	Potassium Citrate FDA LinkGeneric 01/2020
1	Citric Acid (Citrate)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Cystine (L-Cystine)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019
1	CytokinesIBA 10/2019
1	PHEX Phosphate Regulating Neutral EndopeptidaseIBA 01/2019
1	AutoantibodiesIBA 12/2018
1	Hormones (Hormone)IBA 12/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Parathyroid Hormone (Parathormone)IBA 01/2018
1	SteroidsIBA 01/2018
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2011
1	Proteins (Proteins, Gene)FDA Link 11/2007
1	25-hydroxyvitamin DIBA 08/2007

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2018
2	Kidney Transplantation 01/2018 - 11/2016
1	Immunomodulation 12/2018